Abstract
A field study was carried out on 13 workers exposed to styrene vapors at time-weighted average concentrations between 10 and 73 ppm. The reactive intermediate styrene-7,8-oxide was determined in blood samples using a direct gas chromatographic method. Styrene-7,8-oxide concentrations were in the range between 0.9 and 4.1 μg/l blood. Linear correlations were found between styrene-7,8-oxide in blood and styrene in ambient air and blood. For an exposure concentration of 20 ppm styrene (German MAK value) a steady-state level of about 1 μg styrene-7,8-oxide/l blood was calculated.
References
Angerer J, Gündel J, Knecht U, Korn M (1994) Benzol und Alkylbenzole (BTX-Aromaten). In: Henschler D (ed): Analytische Methoden. Analysen in biologischem Material. Band 2. 11. Lieferung. Verlag Chemie, Weinheim
Barale R (1991) The genetic toxicology of styrene and styrene oxide. Mutat Res 257: 107–126
Bardodej Z, Bardodejova E (1970) Biotransformation of ethylbenzene, styrene and alpha-methylstyrene in man. Am Ind Hyg Assoc J 31: 206–209
Bartolucci GB, De Rosa E, Gori GP, Corona Chiesura, Perbellini L, Brugnone F (1986) Biomonitoring of occupational exposure to styrene. Appl Ind Hyg 3: 125–131
Battistini C, Bellucci G, Mastrorilli E (1979) The formation of phenylethane 1,2-diol 2-acetate in the metabolism of styrene oxide by rabbit liver microsomes in vitro. Xenobiotica 9: 57–61
Brugnone F, Perbellini L, Wang GZ, Maranelli G, Raineri E, DeRosa E, Saletti C, Soave C, Romeo L (1993) Blood styrene concentrations in “normal” population and in exposed workers 16 hours after the end of the workshift. Int Arch Occup Environ Health 65: 125–130
Caperos JR, Humbert B, Droz PO (1979) Exposition au styrène. II. Bilan de l'absorption, de l'excrétion et du métabolisme sur des sujets humains. Int Arch Occup Environ Health 42: 223–230
Christakopoulos A, Bergmark E, Zorcec V, Norppa H, Mäki-Paakkanen J, Osterman-Golkar S (1993) Monitoring occupational exposure to styrene from hemoglobin adducts and metabolites in blood. Scand J Work Environ Health 19: 255–263
Conti B, Maltoni C, Perino G, Ciliberti A (1988) Long-term carcinogenicity bioassays on styrene administered by inhalation, ingestion and injection and styrene oxide administered by ingestion in Sprague-Dawley rats, and para-methylstyrene administered by ingestion in Sprague-Dawley rats and Swiss mice. Ann NY Acad Sci 534: 203–234
Csanády GyA, Mendrala AL, Nolan RJ, Filser JG (1994) A physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse, rat and man. Arch Toxicol 68: 143–157
Diem K, Lentner C (1975) Documenta Geigy. Wissenschaftliche Tabellen. 7th edn. Georg Thieme, Stuttgart, p 61
Fernández JG, Caperos JR (1977) Exposition au Styrène. I. Etude expérimentale de l'absorbtion et de l'exrétion pulmonaires sur des sujets humains. Int Arch Occup Environ Health 40: 1–12
Filser JG, Schwegler U, Csanády GyA, Greim H, Kreuzer PE, Kessler W (1993) Species-specific pharmacokinetics of styrene in rat and mouse. Arch Toxicol 67: 517–530
Guillemin MP, Bauer D (1979) Human exposure to styrene. III. Elimination kinetics of urinary mandelic and phenylglyoxylic acids after single experimental exposure. Int Arch Occup Environ Health 44: 249–263
Guillemin MP, Berode M (1988) Biological monitoring of styrene: a review. Am Ind Hyg Assoc J 49: 497–505
Henschler D (ed) (1987) Styrol. Toxikologisch-Arbeitsmedizinische Begründung von MAK-Werten, 13th edn. Verlag Chemie, Weinheim
Kessler W, Jiang X, Filser JG (1990) Direct determination of styrene-7,8-oxide in blood by gas chromatography with flame ionization detection. J Chromatogr 534: 67–75
Kessler W, Jiang X, Filser JG (1992) Pharmakokinetik von Styrol-7,8-oxid bei Maus und Ratte. In: Kreutz R, Piekarski D (eds) Verhandlungen der Deutschen Gesellschaft für Arbeitsmedizin e. V., 32. Jahrestagung 1992 in Köln. Gentner Verlag, Stuttgart, pp 622–626
Korn M (1988) Problembereiche bei der Einhaltung des neuen MAK-Wertes für Styrol. In: Baumgartner E, Brenner W, Dierich MP, Rutenfranz J (eds) Verhandlungen der Deutschen Gesellschaft für Arbeitsmedizin e.V. gemeinsam mit der Österreichischen Gesellschaft für Arbeitsmedizin, 28. Jahrestagung 1988 in Innsbruck. Gentner Verlag, Stuttgart, pp 705–706
Korn M, Wordarz R, Schoknecht W, Weichardt H, Bayer E (1984) Styrene metabolism in man: gas chromatographic separation of mandelic acid enantiomers in the urine of exposed persons. Arch Toxicol 55: 59–63
Korn M, Wodarz R, Drysch K, Schmahl FW (1987) Stereometabolism of styrene in man. Urinary excretion of chiral styrene metabolites. Arch Toxicol 60: 86–88
Korn M, Podsiadlik E, Gfrörer W (1991) Determination of styrene-7,8-oxide in human blood: a sensitive biological monitoring of styrene exposure? In: Drug metabolism: molecules, models and man. Third International ISSX Meeting, 24–28 June 1991, Amsterdam, p 202
Korn M, Podsiadlik E, Gfrörer W, Filser J, Kessler W (1993) Die Bestimmung von Styrol-7,8-oxid im Plasma und Vollblut als Biomonitoring bei Styrolbelastung. In: Triebig G, Stelzer X (eds) Verhandlungen der Deutschen Gesellschaft für Arbeitsmedizin und Umweltmedizin; 33. Jahrestagung 1993 in Wiesbaden. Gentner Verlag, Stuttgart, pp 451–454
Korn M, Podsiadlik E, Gförer W (1994) Gas chromatographic determination of styrene in alveolar air—sampling technique, calibration, and injection mode. Arch Toxicol (in press)
Lijinski W (1986) Rat and mouse forestomach tumors induced by chronic oral administration of styrene oxide. J Natl Cancer Inst 77: 471–476
Liu SF, Rappaport SM, Pongracz K, Bodell WJ (1988) Detection of styrene oxide-DNA adducts in lymphocytes of a worker exposed to styrene. In: Bartsch H, Hemminki K, O'Neill IK (eds) Methods for detecting DNA damaging agents in humans: applications in cancer epidemiology and prevention. JARC Scientific Publications 89, International Agency for Research on Cancer, Lyon, pp 217–222
Löf A, Lundgren E, Nydahl E-M, Nordqvist MB (1986) Biological monitoring of styrene metabolites in blood. Scand J Work Environ Health 12: 70–74
Maltoni C, Failla G, Kassapidis G (1979) First experimental demonstration of the carcinogenic effects of styrene oxide. Med Lav 5: 358–362
Mendrala AL, Langvardt PW, Nitschke KD, Quast JF, Nolan RJ (1993) In vitro kinetics of styrene and styrene oxide metabolism in rat, mouse, and human. Arch Toxicol 67: 18–27
Ponomarkov V, Cabral JRP, Wahrendorf J, Galendo D (1984) A carcinogenicity study of styrene-7,8-oxide in rats. Cancer Lett 24: 95–101
Ramsey JC, Young JD (1978) Pharmacokinetics of inhaled styrene in rats and humans. Scand J Work Environ Health 4 [Suppl 2]: 84–91
Ramsey JC, Young JD, Karbowski RJ, Chenoweth MB, McCarty LP, Braun WH (1980) Pharmacokinetics of inhaled styrene in human volunteers. Toxicol Appl Pharmacol 53: 54–63
Rappaport SM, Ting D, Jin Z, Yeowell-O'Connell K, Waidyanatha S, McDonald T (1993) Application of Raney nickel to measure adducts of styrene oxide with hemoglobin and albumin. Chem Res Toxicol 6: 238–244
Stewart RD, Dodd HC, Baretta ED, Schaffer AW (1968) Human exposure to styrene vapor. Arch Environ Health 16: 656–662
Wigaeus E, Löf A, Bjuström R, Nordqvist MB (1983) Exposure to styrene. Uptake, distribution, metabolism and elimination in man. Scand J Work Environ Health 9: 479–488
Zinser D, Bittighofer PM, Fliedner TM (1988) Biologisches Monitoring bei Styrol-exponierten Personen. In: Baumgartner E, Brenner W, Dierich MP, Rutenfranz J (eds) Verhandlungen der Deutschen Gesellschaft für Arbeitsmedizin e. V. gemeinsam mit der Österreichischen Gesellschaft für Arbeitsmedizin, Jahrestagung 1988, Innsbruck. Gentner Verlag, Stuttgart, pp 473–476
Author information
Authors and Affiliations
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/BF03035422.
Rights and permissions
About this article
Cite this article
Korn, M., Gfrörer, W., Filser, J.G. et al. Styrene-7,8-oxide in blood of workers exposed to styrene. Arch Toxicol 68, 524–527 (1994). https://doi.org/10.1007/s002040050107
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s002040050107